Stonehage Fleming Financial Services Holdings Ltd Takes Position in Cigna Group $CI

Stonehage Fleming Financial Services Holdings Ltd purchased a new position in Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,997 shares of the health services provider’s stock, valued at approximately $1,102,000.

Other large investors also recently made changes to their positions in the company. Assetmark Inc. raised its position in shares of Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after purchasing an additional 5,963 shares during the period. Mystic Asset Management Inc. bought a new stake in shares of Cigna Group during the 2nd quarter worth $2,808,000. KBC Group NV grew its stake in Cigna Group by 6.4% in the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after buying an additional 22,978 shares during the last quarter. Sanctuary Advisors LLC bought a new position in Cigna Group in the 2nd quarter worth $11,043,000. Finally, HighTower Advisors LLC raised its holdings in Cigna Group by 402.7% in the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock worth $97,701,000 after acquiring an additional 283,897 shares during the period. Institutional investors own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the subject of a number of recent analyst reports. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Mizuho increased their target price on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Guggenheim raised their target price on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, UBS Group lifted their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Insider Activity at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 23,012 shares of company stock worth $6,386,550 in the last three months. 0.60% of the stock is owned by insiders.

Cigna Group Stock Performance

NYSE CI opened at $277.21 on Friday. The company’s fifty day moving average is $283.53 and its two-hundred day moving average is $281.41. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The firm has a market capitalization of $73.25 billion, a price-to-earnings ratio of 11.47, a P/E/G ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the business earned $7.20 earnings per share. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.